Therapy Areas: Oncology
20 November 2018 - Genmab A/S (CPH:GEN), a biotechnology company specialising in the creation and development of differentiated antibody therapeutics for the treatment of cancer, announced on Monday t...
20 November 2018 - Armas Pharmaceuticals Incorporated, a New Jersey based multisource pharmaceutical corporation, is launching its first injectable, Azacitidine for Injection 100 MG, in the United Sta...
20 November 2018 - Anglo–Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca's Imfinzi (durvalumab) monotherapy and the combination of Imfinzi with remelimumab ha...
20 November 2018 - - The Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion for apalutamide, a next generation oral androgen receptor inhibit...
19 November 2018 - - Data from the dose escalation portion of its Phase 1 trial of SY-1365, its first-in-class selective cyclin-dependent kinase 7 inhibitor, demonstrated proof-of-mechanism at tolerab...
19 November 2018 - - US-based antibiotics developer Oragenics, Inc. (NYSE American: OGEN) has received clearance to enroll patients residing in Germany from the Paul Erlich Institute and patients resi...
Related Headlines